NCT07277608

Brief Summary

To clarify the clinical features of patients with obstructive sleep apnea; To construct a multi-omics database of patients with obstructive sleep apnea, and compare the effects of different degrees of sleep apnea on prognosis, immunity, and metabolism. The medium and long-term prognosis, complications, comorbidities, risk factors, and immune and metabolic dynamics of patients with sleep apnea after treatment were studied. To elucidate the biomarkers and therapeutic targets associated with obstructive sleep apnea.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
89mo left

Started Aug 2023

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress28%
Aug 2023Aug 2033

Study Start

First participant enrolled

August 7, 2023

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 3, 2024

Completed
1.9 years until next milestone

First Posted

Study publicly available on registry

December 11, 2025

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 7, 2033

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 7, 2033

Last Updated

December 11, 2025

Status Verified

April 1, 2025

Enrollment Period

10 years

First QC Date

January 3, 2024

Last Update Submit

November 29, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Multiple-omics features

    ELISA ,proteomics and metabolomics were performed on blood, saliva, urine

    Within 24 hours of admission,and samples of patients receiving treatment were also collected six months and one year after treatment

Study Arms (3)

Severe OSA

Non-severe OSA

Healthy controls

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with obstructive sleep apnea.

You may qualify if:

  • Patients with suspected obstructive sleep apnea (OSA) admitted to the sleep center of the respiratory Department of Beijing Chaoyang Hospital, Capital Medical University.
  • Volunteer to participate in the study and sign an informed consent, and can complete at least 1 year of follow-up.

You may not qualify if:

  • Patients with obstructive sleep apnea who have been treated with impermanent positive pressure ventilation;
  • Pregnant or lactating women;
  • Patients with severe respiratory failure requiring mechanical ventilation;
  • Patients with severe heart, lung, liver, kidney, and central nervous system damage;
  • Refuse to participate in follow-up visits and/or take biological samples.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Beijing Chaoyang hospital affiliated to Capital Medical University

Beijing, Beijing Municipality, 100020, China

RECRUITING

MeSH Terms

Conditions

Sleep Apnea, Obstructive

Condition Hierarchy (Ancestors)

Sleep Apnea SyndromesApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
professor

Study Record Dates

First Submitted

January 3, 2024

First Posted

December 11, 2025

Study Start

August 7, 2023

Primary Completion (Estimated)

August 7, 2033

Study Completion (Estimated)

August 7, 2033

Last Updated

December 11, 2025

Record last verified: 2025-04

Locations